NCT00002289View on ClinicalTrials.gov

The Effects of Thymopentin on HIV Infectivity of Blood Cells and Semen in HIV-Infected Patients

NACompletedINTERVENTIONAL
Timeline

Start Date

Not specified

Conditions
HIV Infections
Interventions
DRUG

Thymopentin

Trial Locations (1)

088010999

Immunobiology Research Institute, Annandale

Sponsors
All Listed Sponsors
lead

Immunobiology Research Institute

INDUSTRY

NCT00002289 - The Effects of Thymopentin on HIV Infectivity of Blood Cells and Semen in HIV-Infected Patients | Biotech Hunter | Biotech Hunter